PharmaShots | Incisive News in 3 Shots

Subscribe Now

fibrodysplasia ossificans progressiva (FOP)

Ipsen Signs Exclusive Worldwide License Agreement with Blueprint to Develop & Commercialize BLU-782 for Fibrodysplasia Ossificans Progressiva

Ipsen Signs Exclusive Worldwide License Agreement with Blueprint to Develop & Commercialize BLU-782 for Fibrodysplasia Ossific...

October 17, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us